Drug-eluting stents in the management of peripheral arterial disease

Vascular Health and Risk Management

Volumn 4, Issue 3, 2008, Pages 553-559

  Bosiers, Marc ^a   Cagiannos, Catherine ^a   Deloose, Koen ^a   Verbist, Jürgen ^b   Peeters, Patrick ^b  

^a AZ St Blasius ^*  (Belgium)

^b IMELDA HOSPITAL   (Belgium)

Author keywords

Below the knee; Critical limb ischemia; Crural; Drug eluting stent; Infrapopliteal; Limb salvage

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; NITINOL; PACLITAXEL; RAPAMYCIN;

ANKLE BRACHIAL INDEX; BALLOON DILATATION; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; KIDNEY ARTERY STENOSIS; LEG REVASCULARIZATION; LIMB ISCHEMIA; LIMB SALVAGE; MEDLINE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; REVIEW; SUPERFICIAL FEMORAL ARTERY; TREATMENT FAILURE; VASCULAR PATENCY; VERTEBRAL ARTERY STENOSIS;

ARTERIAL OCCLUSIVE DISEASES; CAROTID STENOSIS; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; FEMORAL ARTERY; HUMANS; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RENAL ARTERY;

EID: 47849129694     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Abou-Chebl A, Bashir Q, Yadav JS. 2005. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke, 36:165-8.
2. Bosiers M, Deloose K, Verbist J, et al. 2006. Percutaneous transluminal angioplasty for treatment of "below-the-knee" critical limb ischemia: early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg(Torino), 47:171-6.
3. Bosiers M, Deloose K, Verbist J, et al. 2007. Nitinol stenting for treatment of 'below-the-knee' critical limb ischemia: 1 year angiographic outcome of the Xpert stent. J Cardiovasc Surg(Torino), 48:455-61.
4. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. 2005. Warfarin-aspirin symptomatic intracranial disease trial investigators: comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med, 352:1305-16.
5. Commeau P, Barragan P, Roquebert PO. 2006. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv, 68:793-8.
6. Diener HC, Bogousslavsky J, Brass LM, et al.; MATCH Investigators. 2004. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet, 364:331-7.
7. Duda SH, Pusich B, Richter G, et al. 2002. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-month results. Circulation, 106:1505-9.
8. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: The SIROCCO II trial. J Vasc Interv Radiol, 16:331-8.
9. Duda SH, Bosiers M, Lammer J, et al. 2006. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long-term results from the SIROCCO trial. J Endovasc Ther, 13:701-10.
10. Eisenstein EL, Anstrom KJ, Kong DF, et al. 2007. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA, 297:159-68.
11. Feiring AJ, Wesolowski AA, Lade S. 2004. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol, 44:2307-14.
12. Feiring AJ, Wesolowski AA. 2007. Antegrade popliteal artery approach for the treatment of critical limb ischemia in patients with occluded superficial femoral arteries. Catheter Cardiovasc Intervi, 69:665-70.
13. Granillo GA, van Dijk LC, McFadden EP, et al. 2005. Percutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stents. Catheter Cardiovasc Interv, 64:23-7.
14. Gupta R, Al-Ali F, Thomas AJ, et al. 2006. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke, 37:2562-6.
15. Harper RW. 2007. Drug-eluting stents coronary stents - a note of caution. Med J Aust, 186:253-5.
16. Hill R, Bagust A, Bakhai A, et al. 2004. Coronary artery stents: a rapid systematic review and economic evaluation. Health Technol Assess, 8(35):iii-iv, 1-242.
17. Holmes DR, Leon MB, Moses JW, et al. 2004. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation, 109:634-40.
18. Kakkar AK, Fischi M, Narins CR. 2006. Drug-eluting stent implantation for treatment of recurrent renal artery in-stent restenosis. Catheter Cardiovasc Interv, 68:118-22; discussion 123-4.
19. Kasner SE, Chimowitz MI, Lynn MJ, et al. 2006. Warfarin Aspirin symptomatic intracranial disease trial. Circulation, 113:555-63.
20. Ko Y-G, Park S, Kim J-Y, et al. 2004. Percutaneous interventional treatment of extracranial vertebral artery stenosis with coronary stents. Yonsei Med J, 45:629-34.
21. Levy EI, Hanel RA, Howington JU, et al, 2004. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg, 100:688-94.
22. Mauri L, Orav EJ, Candia SC, et al. 2005. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation, 112:2833-9.
23. Moreno R, Fernandez C, Hernandez R, et al. 2005. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol, 45:954-9.
24. Norgren L, Hiatt WR, Dormandy JA, et al. 2007. TASC II working group. Intersociety consensus for the mangement of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg, 33(Suppl 1):S1-75.
25. Nussbaumer-Ochsner Y, Eberli FR, Baumgartner RW, et al. 2006. Sirolimus-eluting stenting of the external carotid artery for the treatment of ocular ischemia. J Endovasc Ther, 13:672-5.
26. Qureshi AI, Kirmani JF, Hussein HM, et al. 2006. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery, 59:1044-51.
27. Roiron C, Sanchez P, Bouzamondo A, et al. 2006, Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart, 92:641-9.
28. Sapoval M, Zahringer M, Pattynama P, et al. 2005. Low-profile stent system for treatment of atherosclerotic renal artery stenosis: The GREAT trial. J Vasc Interv Radiol, 16:1195-202.
29. Scheinert D, Ulrich M, Scheinert S, et al. 2006. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroInterv, 2:169-74.
30. Schwarzmaier-D'Assie A, Karnik R, et al. 2007. Fracture of a drug-eluting stent in the tibioperoneal trunk following bifurcation stenting. J Endovasc Ther, 14:106-9.
31. Siablis D, Kraniotis P, Karnabatidis D, et al. 2005. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther, 12:685-95.
32. Siablis D, Karnabatidis D, Katsanos K, et al. 2007. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther, 14:241-50.
33. Stone GW, Ellis SG, Cox DA, et al. 2004. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation, 109:1942-7.
34. SSYLVIA Investigators. 2004. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke, 35:1388-92.
35. Waksman R. 2006. Update on bioabsorbable stents: From bench to clinical. J Interven Cardiol, 19:414-21.
36. Zähringer M, Sapoval M, Pattynama PMT, et al. 2007. Sirolimus-elutinG versus bare-metal low-profile stent for REnal Artery Treatment (GREAT trial): Angiographic follow-up after 6 month and clinical outcome up to 2 years. J Endovasc Ther, 14:460-8.
37. Zeller T, Rastan A, Rothenpieler U, et al. 2006. Restenosis after stenting of atherosclerotic renal artery stenosis: Is there a rationale for the use of drug-eluting stents? Catheter Cardiovasc Interv, 68:125-30.